Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

After more than four decades of dedicated service in health care, Costa King Cockfield, chief nursing officer for MUSC Health ...

And it is not the only one coming to the area. The Medical University of South Carolina celebrated the "topping out," an event commemorating the placement of the last steel beam, of the MUSC ...

Acoramidis’s hazard ratio of .41 for time to ACM or first CVH versus placebo in the ATTRibute-CM study subgroup of ATTRv-CM patients achieved ...

a fan exclaimed. "Well. One team's actual logo IS 'SC'. The other is a C with a Pigeon in it," one fan mocked South Carolina logo. Fans might not have to even wait till the end of 2025 to see the ...

Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to newborns with Neonatal Opioid Withdrawal Syndrome ...

Dr. Manning III completed a residency at Medical University of South Carolina. At present, Dr. Manning III has received an average rating of 5.0 from patients and has been reviewed 16 times.

director of the aerospace neurology and human performance program at the Medical University of South Carolina, told TODAY. "Their immune system has been suppressed over a period of time." ...

Online Programs in professional areas with the largest enrollments are evaluated annually by U.S. News, based on criteria such as employment outcomes of graduates.

The Gamecocks will play for their third title in four seasons. They'll have to beat UConn on Sunday to earn it.